Shanda Lightbown

Editor’s summary Abstract Supplementary Materials References and Notes Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary Engineered bacteria could serve as a source of long-term drug delivery, but they tend to escape confinement because of their small size and robust viability. Harimoto et al.

Abstract Broad-spectrum therapeutics capable of inhibiting SARS-CoV-2, its variants, and related coronaviruses hold promise in curbing the spread of COVID-19 and averting future pandemics.